SGH
WST icon

Sivik Global Healthcare’s West Pharmaceutical WST Stock Holding History

Sivik Global Healthcare’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,000
Closed -$3.94M – 55
2025
Q3 		$3.94M Hold
15,000
– – 2.07% 36
2025
Q2 		$3.28M Buy
15,000
+2,500
+20% +$534K 1.47% 36
2025
Q1 		$2.8M Buy
+12,500
New +$3.45M 1.53% 28
2024
Q4 		– Sell
-17,000
Closed -$5.1M – 48
2024
Q3 		$5.1M Buy
17,000
+4,000
+31% +$1.22M 2.18% 21
2024
Q2 		$4.28M Buy
13,000
+3,000
+30% +$1.06M 1.91% 28
2024
Q1 		$3.96M Buy
+10,000
New +$3.7M 1.44% 33
2022
Q1 		– Sell
-7,500
Closed -$3.52M – 59
2021
Q4 		$3.52M Buy
+7,500
New +$3.23M 1.51% 32

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return